NCT03322293 2022-03-09Daylight Photodynamic Therapy for Actinic KeratosisUniversity of California, San FranciscoPhase 1 Completed24 enrolled 15 charts
NCT01976741 2021-05-06Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib)BayerPhase 1 Completed168 enrolled 59 charts